Smartkarma Research Team, Smartkarma

Smartkarma Research

Smartkarma Research Team

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<p>For our next Corporate Webinar we are glad to welcome <a href="https://www.smartkarma.com/entities/trendlines-group-ltd" target="_blank" data-smartkarma-citation="entities:27237" rel="noopener">Trendlines Group Ltd (TTGL SP)</a> Chairman &amp; CEO, Steve Rhodes.</p>
<p>In the upcoming webinar, Steve will share a short company presentation after which, he will engage in a fireside chat with Smartkarma Insight Provider, <a href="https://www.smartkarma.com/profiles/sameer-taneja-a0539e0c-84dd-4e66-9c40-6e598edfb4c5/about" target="_blank" rel="noopener">Sameer Taneja</a>. A live Q&amp;A session will follow.</p>
<h3>The Corporate Webinar will be hosted on Tuesday, 1 March 2022, 17:00 SGT.</h3>
<div class="content-highlight">
<h2><a href="https://share.hsforms.com/1H9pFZOB-RF2J00kbvMmxcw2c5gj?zoom_webinar_id=83180730751" target="_blank" rel="noopener">Register for the Webinar here</a></h2>
</div>
<p>Trendlines invent, discover, invest in, and incubate innovation-based medical and agricultural technologies. They invest principally through their incubators: </p>
<ul>
<li dir="ltr" style="list-style-type: disc;" aria-level="1">
<p>Israeli government-franchised incubators - Trendlines Medical and Trendlines Agtech</p>
</li>
<li dir="ltr" style="list-style-type: disc;" aria-level="1">
<p>Singapore incubators - Trendlines Medical Singapore and AFIC (agrifood incubator)</p>
</li>
<li dir="ltr" style="list-style-type: disc;" aria-level="1">
<p>In-house innovation center - Trendlines Labs</p>
</li>
<li dir="ltr" style="list-style-type: disc;" aria-level="1">
<p>Funds - Trendlines Agrifood Fund and Bayer Trendlines Ag Innovation Fund. </p>
</li>
</ul>
<p> As intensely hands-on investors, they are involved in all aspects of their portfolio companies from technology development to business building.  Simply stated, Trendlines create and develop companies to improve the human condition.</p>
<p>Corporate Webinars by <a href="https://www.smartkarma.com/home/corporate-solutions/" target="_blank" rel="noopener">Smartkarma Corporate Solutions</a> feature discussions with IROs and Executives, discussing their companies, the challenges they face, and the opportunities in their sectors and markets.</p>

For our next Corporate Webinar we are glad to welcome Trendlines Group Ltd (TTGL SP) Chairman &amp; CEO, Steve Rhodes.
In the upcoming webinar, Steve will share a short company presentation after which, he will engage in a fireside chat with Smartkarma Insight Provider, Sameer Taneja. A live Q&amp;A session will follow.
The Corporate Webinar will be hosted on Tuesday, 1 March 2022, 17:00 SGT.

Register for the Webinar here

Trendlines invent, discover, invest in, and incubate innovation-based medical and agricultural technologies. They invest principally through their incubators: 


Israeli government-franchised incubators - Trendlines Medical and Trendlines Agtech


Singapore incubators - Trendlines Medical Singapore and AFIC (agrifood incubator)


In-house innovation center - Trendlines Labs


Funds - Trendlines Agrifood Fund and Bayer Trendlines Ag Innovation Fund. 


 As intensely hands-on investors, they are involved in all aspects of their portfolio companies from technology development to business building.  Simply stated, Trendlines create and develop companies to improve the human condition.
Corporate Webinars by Smartkarma Corporate Solutions feature discussions with IROs and Executives, discussing their companies, the challenges they face, and the opportunities in their sectors and markets.

Smartkarma Corporate Webinar | Trendlines: Innovation in Agri and Med Tech

SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Asia’s leading multi-asset exchange

Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

<div>
<div>
<div>
<p><em><strong>Non- SGX Report: These equity research reports are not written by the SGX.&nbsp;</strong>SGX supports the distribution of the research reports by external contributors. Please refer to the Disclaimer in the attached report.</em></p>
<h2>Trendlines Group: What gives this tech incubator a winning formula?</h2>
</div>
</div>
<div>
<div>
<div>
<p>Trendlines Group, an Israeli tech incubator, has been a severely undervalued stock. We like this stock as it is in a unique position to reap the exciting growth opportunities that exist within the medtech and agtech space.</p>
<div>
<div>
<div>
<p><strong>Analyst: Chloe Nadia Halim | Published on 16 Nov 2020</strong></p>
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/182/774/original/image_67474909431610739943176.png?1610739949" class="editor-image img-responsive" data-smartkarma-image-id="182774"></figure>
<div>
<div>
<div>
<p style="text-align: right;">Photo by Diego on Unsplash</p>
<div>
<div>
<div>
<ul>
<li>The Trendlines Group (SGX: 42T) is an Israel-based incubator that invests in early-stage, high growth, innovation-based start-up companies with a view towards a successful exit in the marketplace.</li>
<li>Trendlines focuses on medical (medtech) and agricultural technologies (agtech), and leverages on non-dilutive government funding in Israel and Singapore to accelerate the growth of its portfolio companies.</li>
<li>By partnering with industry leaders, Trendlines is able to tap on their expertise and capital to further support its portfolio companies.</li>
<li>To mitigate the risk of irregular cash flows, Trendlines is building up a portfolio of royalty and future payments that will contribute to its cash flow on a more consistent basis.</li>
<li>We maintain our target price of SGD 0.125 for Trendlines Group, based on a fair price-to-book (PB) ratio of 0.75X. Based on the closing price of SGD 0.084 on 13 November 2020, this translates to an upside potential of 48%.</li>
</ul>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>




Non- SGX Report: These equity research reports are not written by the SGX.&nbsp;SGX supports the distribution of the research reports by external contributors. Please refer to the Disclaimer in the attached report.
Trendlines Group: What gives this tech incubator a winning formula?





Trendlines Group, an Israeli tech incubator, has been a severely undervalued stock. We like this stock as it is in a unique position to reap the exciting growth opportunities that exist within the medtech and agtech space.



Analyst: Chloe Nadia Halim | Published on 16 Nov 2020




Photo by Diego on Unsplash




The Trendlines Group (SGX: 42T) is an Israel-based incubator that invests in early-stage, high growth, innovation-based start-up companies with a view towards a successful exit in the marketplace.
Trendlines focuses on medical (medtech) and agricultural technologies (agtech), and leverages on non-dilutive government funding in Israel and Singapore to accelerate the growth of its portfolio companies.
By partnering with industry leaders, Trendlines is able to tap on their expertise and capital to further support its portfolio companies.
To mitigate the risk of irregular cash flows, Trendlines is building up a portfolio of royalty and future payments that will contribute to its cash flow on a more consistent basis.
We maintain our target price of SGD 0.125 for Trendlines Group, based on a fair price-to-book (PB) ratio of 0.75X. Based on the closing price of SGD 0.084 on 13 November 2020, this translates to an upside potential of 48%.















(Non-SGX Report) Trendlines Group: What Gives This Tech Incubator a Winning Formula?

<p><em><strong>Non- SGX Report: These equity research reports are not written by the SGX.</strong>&nbsp;SGX supports the distribution of the research reports by external contributors. Please refer to the Disclaimer in the attached report.</em></p>
<p><span>Trendlines Group: A tech incubator with immense upside potential</span></p>
<div>
<div>
<div>
<div>
<p>Trendlines Group, an Israeli tech incubator, has been a severely undervalued stock. However, it has exciting growth prospects, as it is well-positioned to benefit from the booming Medtech and Agtech sectors.</p>
<ul>
<li>Catalist-listed The Trendlines Group (SGX.42T) is an Israel-based incubator that invests in in early- stage, high growth, innovation-based start-up companies with a view towards a successful exit in the marketplace</li>
<li>It focuses on medical (Medtech) and agricultural technologies (Agtech), both of which are beneficiaries of trends such as an ageing global population and an increasing demand for food and nutritional security</li>
<li>Trendlines has built up a strong track record, and coupled with the vibrant start-up ecosystem in Israel, it is in a good position to benefit from such global trends</li>
<li>For individual investors, there are a limited few publicly listed incubators in the world, and other avenues to invest in incubators via a venture capital firm or direct investments are often out of reach, and hence Trendlines fills this gap</li>
<li>Our target price of SGD 0.125 for Trendlines Group is based on a fair price-to-book (PB) ratio of 0.75X. We rate the stock as a strong buy, with an upside potential of about 45%</li>
</ul>
</div>
</div>
</div>
</div>

Non- SGX Report: These equity research reports are not written by the SGX.&nbsp;SGX supports the distribution of the research reports by external contributors. Please refer to the Disclaimer in the attached report.
Trendlines Group: A tech incubator with immense upside potential




Trendlines Group, an Israeli tech incubator, has been a severely undervalued stock. However, it has exciting growth prospects, as it is well-positioned to benefit from the booming Medtech and Agtech sectors.

Catalist-listed The Trendlines Group (SGX.42T) is an Israel-based incubator that invests in in early- stage, high growth, innovation-based start-up companies with a view towards a successful exit in the marketplace
It focuses on medical (Medtech) and agricultural technologies (Agtech), both of which are beneficiaries of trends such as an ageing global population and an increasing demand for food and nutritional security
Trendlines has built up a strong track record, and coupled with the vibrant start-up ecosystem in Israel, it is in a good position to benefit from such global trends
For individual investors, there are a limited few publicly listed incubators in the world, and other avenues to invest in incubators via a venture capital firm or direct investments are often out of reach, and hence Trendlines fills this gap
Our target price of SGD 0.125 for Trendlines Group is based on a fair price-to-book (PB) ratio of 0.75X. We rate the stock as a strong buy, with an upside potential of about 45%






Non-SGX Report: Trendlines Group: A Tech Incubator with Immense Upside Potential

Israel

The Trendlines Group Ltd is a commercialization company that creates and develops companies to improve the human condition. The Company invents, discovers, invests in, and incubates medical and agricultural technologies. Trendlines Group is involved in all aspects of its portfolio companies from technology development to business building.

Trendlines Group Ltd (TTGL SP)

Smartkarma Corporate Webinar | Trendlines: Innovation in Agri and Med Tech

On 1 March, 5pm SGT, join our Webinar with Trendlines Chairman & CEO Steve Rhodes, speaking to Insight Provider Sameer Taneja about the company and...

Smartkarma Research

(Non-SGX Report) Trendlines Group: What Gives This Tech Incubator a Winning Formula?

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Singapore Exchange Ltd (SGX)

Non-SGX Report: Trendlines Group: A Tech Incubator with Immense Upside Potential

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Singapore Exchange Ltd (SGX)